KENYA – National Aids Control Council (NACC) CEO Ruth Masha has said the committee convened by the council held a series of meetings with US representatives where all outstanding issues…
Read MoreMonth: June 2021
Emergex’s dengue vaccine candidate receives regulatory approval for its first phase clinical trial
UK – A company tackling major global infectious disease threats through the development of 100% synthetic ‘set point’ vaccines, Emergex Vaccines Holding has received regulatory approval for its phase 1…
Read MoreCOVID-19 tourism impact could top US$4 trillion loss in developing countries
AFRICA – The economic impact from the plunge in tourism since the pandemic emerged last year could top US$4 trillion, a UN report has said. The joint report by the…
Read MoreRwanda tightens restriction measures, including school closure, as Uganda approves Covidex
RWANDA – Rwanda has announced a review of COVID-19 restriction measures due to a surge in cases and the emergence of new variants globally. Schools and higher education institutions in…
Read MoreSerengeti Breweries unveils TSH 2.3b fund to help bars fight against communicable diseases in Tanzania
TANZANIA – Serengeti Breweries Limited (SBL), Tanzania’s leading brewing company, has announced a programme worth over TSH. 2.3 billion (US$ 992,000) to support bars and eateries in Dar es Salaam…
Read MoreSwift medical partners with Accentcare as it aims to venture into the home-based health market
CANADA – Digital wound care start-up Swift Medical is partnering with one of the largest home health providers, AccentCare, to get its technology into the hands of thousands of care…
Read MoreEmzor’s ultra-modern pharmaceutical factory receives government acclamation
NIGERIA – The Federal Government has lauded Nigeria’s leading indigenous pharmaceutical company, Emzor Pharmaceutical Industries Limited, for the indispensable role it has been playing in the nation’s pharmaceutical sector, especially…
Read MoreLilly’s tirzepatide tops list ahead of ozempic as treatment candidate for type 2 diabetes
US – In the just concluded phase 3 trials, the American pharmaceutical company, Eli Lilly have provided results that showed its investigational Gastric inhibitory polypeptide (GIP) and Glucagon-like peptide 1…
Read MoreA study to map out Nigeria’s pharmaceutical supply chain has been launched
NIGERIA – The Lagos Business School Sustainability Centre (LBSSC) and Bloom Public Health, in partnership with some Nigerian regulatory bodies have launched a study to map out the pharmaceutical supply…
Read More‘Mix match’ COVID-19 vaccine approach under consideration following promising results
UK – The UK based Com-Cov study, involving trial usage of two different COVID-19 vaccines, that began early this year has brought back positive with data showing it is still…
Read More